Paul always seems buoyant, excited etc. etc. in
those paid for investment interviews.
All part of the sales pitch.
It’s a pity the investment community doesn’t share
the same level of excitement.
Further CelGro® nerve clinical trial data from all patients at 12 months, page-24
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
64.0¢ |
Change
0.090(16.4%) |
Mkt cap ! $134.1M | |||
| Open | High | Low | Value | Volume |
| 56.5¢ | 67.0¢ | 56.5¢ | $1.458M | 2.347M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 32802 | 63.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 64.0¢ | 10275 | 2 |
View Market Depth
| Last trade - 13.48pm 10/10/2024 (20 minute delay) ? |
| OCC (ASX) Chart |